FindTrial
Sign In

Study of lactate dehydrogenase and platelets in patients with Immune thrombocytopenic purpura

Study of Lactate dehydrogenase (LDH) and Platelet indices in Immune thrombocytopenic purpura (ITP).

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/048988
Enrollment
73
Registered
2023-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: D899- Disorder involving the immune mechanism, unspecified

Interventions

None listed

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed ITP cases. Secondary ITP, including : -Autoimmune syndromes -HIV, hepB and C -Immunodeficiency syndromes -Vaccine induced

Exclusion criteria

Exclusion criteria: -Hemolytic anemias -Vitamin B12 and folate deficiency -Drug induced -Active infections -Underlying CLD -Drug induced

Design outcomes

Primary

MeasureTime frame
Assessment of Platelet indices and LDH and studying the association with severity of ITPTimepoint: Assessment of Platelet indices and LDH and studying the association with severity of ITP at the time of admission (before starting treatment)—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Alekhya Shetty Kandukuri

Kasturba Hospital, Manipal

shubhada.u@manipal.edu9844465447

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026